Literature DB >> 7869284

Who is at risk of limb loss and what to do about it?

G E Reiber1.   

Abstract

Lower limb amputations were performed on over 105,000 individuals in United States short-stay hospitals between 1989 and 1992. Additional amputations were performed in VA, military, Indian Health, and charitable orthopaedic hospitals. Half of all lower extremity amputations occurred in individuals with diabetes. When the causal chain leading to diabetic amputations was examined in 80 consecutive patients at the VA Medical Center, Seattle, WA, 23 unique pathways were identified. Multiple pathway components were identified for 96% of patients, while in 4% a single ischemic pathway was sufficient in itself to require amputation. The majority of the scenarios leading to amputation began when patients with absent peripheral sensation sustained a pivotal event that initiated the causal chain to amputation. In nearly half the patients, this event was foot-wear-related. The pivotal event was followed by ulceration and faulty wound healing in 73% of patients. Each year thousands of individuals with diabetes undergo amputation in VA facilities, resulting in substantial cost to the Department of Veterans Affairs and to themselves. If the VA is to address the prevention or delay of limb loss, the causal pathway information indicates that attention to the footwear of diabetic patients is necessary.

Entities:  

Mesh:

Year:  1994        PMID: 7869284

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  9 in total

1.  Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score.

Authors:  Stephan Kress; Helmut Anderten; Anja Borck; Guido Freckmann; Lutz Heinemann; Ulrike Holzmüller; Bernd Kulzer; Alexandra Portele; Oliver Schnell; Helga Varlemann; Claudia Zemmrich; Ralf Lobmann
Journal:  J Diabetes Sci Technol       Date:  2020-06-10

2.  Costs of deep foot infections in patients with diabetes mellitus.

Authors:  G R Tennvall; J Apelqvist; M Eneroth
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

3.  [Special manufactured shoes for prevention of recurrent ulcer in diabetic foot syndrome].

Authors:  F Striesow
Journal:  Med Klin (Munich)       Date:  1998-12-15

4.  Comparison of shoe-length fit between people with and without diabetic peripheral neuropathy: a case-control study.

Authors:  Alistair D McInnes; Farina Hashmi; Lisa J Farndon; Amanda Church; Maria Haley; Debora M Sanger; Wesley Vernon
Journal:  J Foot Ankle Res       Date:  2012-04-16       Impact factor: 2.303

Review 5.  Osseointegrated prostheses for rehabilitation following amputation : The pioneering Swedish model.

Authors:  Yan Li; Rickard Brånemark
Journal:  Unfallchirurg       Date:  2017-04       Impact factor: 1.000

6.  Cost of managing complications resulting from type 2 diabetes mellitus in Canada.

Authors:  Judith A O'Brien; Amanda R Patrick; J Jaime Caro
Journal:  BMC Health Serv Res       Date:  2003-03-21       Impact factor: 2.655

Review 7.  Techniques for Interface Stress Measurements within Prosthetic Sockets of Transtibial Amputees: A Review of the Past 50 Years of Research.

Authors:  Ebrahim A Al-Fakih; Noor Azuan Abu Osman; Faisal Rafiq Mahmad Adikan
Journal:  Sensors (Basel)       Date:  2016-07-20       Impact factor: 3.576

8.  Examination of the Effect of Suitable Size of Shoes under the Second Metatarsal Head and Width of Shoes under the Fifth Metatarsal Head for the Prevention of Callus Formation in Healthy Young Women.

Authors:  Ryutaro Kase; Ayumi Amemiya; Rena Okonogi; Hiroki Yamakawa; Hisayoshi Sugawara; Yuji L Tanaka; Masatoshi Komiyama; Taketoshi Mori
Journal:  Sensors (Basel)       Date:  2018-09-28       Impact factor: 3.576

9.  Coencapsulation of ISCs and MSCs Enhances Viability and Function of both Cell Types for Improved Wound Healing.

Authors:  Ayesha Aijaz; Matthew Teryek; Michael Goedken; Marianne Polunas; Ronke M Olabisi
Journal:  Cell Mol Bioeng       Date:  2019-07-01       Impact factor: 2.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.